Riskpilot← Back to searchSign inGet full accessBETHS MEDISPA AS
ASActiveOrg 999327427Niels Juels gate 38, 0257 OsloOther human health activities n.e.c. · NACE 8699Est. 201313 employees
Revenue 2024
NOK 48,1M
+12% vs 2023
EBITDA margin
17.1%
-3% vs 2023
Equity ratio
47.2%
Financial strength
Net profit 2024
NOK 5,3M
+4% vs 2023
| Revenue | NOK 48,1M | +12% |
| EBITDA | NOK 8,2M | -3% |
| Net profit | NOK 5,3M | +4% |
| Total assets | NOK 13,7M | +6% |
| Equity | NOK 6,5M | +5% |
| Employees | 13 | — |
Legal name
BETHS MEDISPA AS
Org number
999327427
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
5. januar 2013
Share capital
NOK 1 000 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Salg av tjenester og tilknyttede produkter innen medisinsk hudpleie.
Address
Niels Juels gate 38, 0257 Oslo
Phone
+4722555380
Email
medispa@beths.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 90 | 7 552 | 17 494 | 22 504 | 26 675 | 34 880 | 40 597 | 44 795 | 53 259 | 53 895 | 46 593 | 42 936 | 48 107 |
| Staff expenses | −0 | −0 | −0 | −853 | −1 412 | −1 668 | −1 721 | −1 749 | −1 762 | −3 384 | −5 341 | −4 963 | −5 555 |
| EBITDA | −157 | 482 | 3 855 | 6 022 | 7 207 | 10 948 | 12 987 | 14 842 | 19 732 | 15 903 | 11 828 | 8 490 | 8 226 |
| Depreciation & amort. | −11 | −82 | −171 | −559 | −671 | −865 | −1 223 | −1 549 | −1 796 | −2 167 | −2 161 | −1 979 | −1 603 |
| EBIT | −168 | 400 | 3 684 | 5 464 | 6 536 | 10 083 | 11 763 | 13 293 | 17 935 | 13 737 | 9 666 | 6 511 | 6 623 |
| Net financials | 0 | 12 | 38 | 3 | 1 | 2 | 23 | 96 | 1 | 5 | −4 | 68 | 199 |
| Profit before tax | −168 | 412 | 3 721 | 5 467 | 6 537 | 10 085 | 11 786 | 13 389 | 17 936 | 13 742 | 9 662 | 6 579 | 6 822 |
| Tax | −50 | 116 | 1 005 | 1 477 | 1 635 | 2 420 | 2 712 | 2 946 | 3 947 | 3 020 | 2 126 | 1 447 | 1 502 |
| Net profit | −118 | 296 | 2 716 | 3 990 | 4 902 | 7 664 | 9 074 | 10 443 | 13 989 | 10 721 | 7 536 | 5 132 | 5 320 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 740 | 2 890 | 7 487 | 8 165 | 9 759 | 13 289 | 15 665 | 18 355 | 23 350 | 20 759 | 14 526 | 12 932 | 13 661 |
| Equity | 871 | 1 167 | 3 883 | 1 193 | 2 095 | 2 760 | 6 834 | 1 004 | 1 004 | 10 730 | 7 110 | 6 132 | 6 453 |
| Long-term debt | 0 | 9 | 0 | 8 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 869 | 1 714 | 3 603 | 6 964 | 7 664 | 10 527 | 8 831 | 17 352 | 22 346 | 10 029 | 7 417 | 6 800 | 7 209 |
| Total debt | 869 | 1 723 | 3 603 | 6 971 | 7 664 | 10 529 | 8 831 | 17 352 | 22 346 | 10 029 | 7 417 | 6 800 | 7 209 |
EBITDA margin
17.1%
This company
15.8%
Market median
+8% vs market
20122024
Equity ratio
47.2%
This company
38.2%
Market median
+24% vs market
20122024
Return on equity
82.5%
This company
18.4%
Market median
+348% vs market
20122024
Net profit margin
11.1%
This company
8.1%
Market median
+37% vs market
20122024
Asset turnover
3.52×
This company
1.12×
Market median
+214% vs market
20122024
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RI Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Beth'S Beauty Holding As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Röko Holding As
BETHS MEDISPA AS Board members of BETHS MEDISPA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Reidun Irene Wang | Chief Executive Officer | 0 companies |
| Elisabeth Lein Oksvik | Board of Directors | 0 companies |
| Lars Johan Bladh | Chairman | 0 companies |
| Anders Nordby | Board of Directors | 0 companies |
| Tomas Gunnar Billing | Board of Directors | 0 companies |